Delivery Order SPE2DB22D9353-SPE2DB25FX2ES
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,266.28 by the Defense Logistics Agency on August 12, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14 units. The delivery order, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by August 13, 2025, and will be fulfilled from the company's Park Ridge...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,316.57 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,754.56 by the Defense Logistics Agency on September 11, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This award leverages DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,316.57 by the Defense Logistics Agency on September 15, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This delivery order, which carries no set-aside designation, is set to be completed by September 16, 2025, with performance taking place at the contractor's Park Ridge facility. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,314.19 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Trikafta 80-40-60mg/59.5mg packets (14-count). This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier to the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,316.57 by the Defense Logistics Agency on September 26, 2025. The delivery order, which is not subject to any set-aside designation, covers the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14, with an ultimate completion date of September 29, 2025. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $112,587.38 by the Defense Logistics Agency on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract covers the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This delivery order was issued without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $75,595.28 by the Defense Logistics Agency (DLA) on September 11, 2025, with a completion date of September 12, 2025. The delivery order covers Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This award was made without a set-aside designation,...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2ESDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $38,633.14 firm fixed-price delivery order by the Defense Logistics Agency for Trikafta 100-50-75 mg/75 mg packets (14-count packages). This delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a specialized pharmaceutical supply supporting military and federal healthcare systems. The award carries no set-aside designation, indicating the company competed on an open basis. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering branded and generic prescription medications, biologics, and medical consumables. The company's consistent success in securing federal contracts reflects its operational capabilities and competitive positioning as a woman-owned small business in the pharmaceutical distribution sector. Trikafta, a cystic fibrosis treatment, exemplifies the specialized therapeutic products the company supplies to support military health system requirements across global locations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.6k | 9/17/25 |